Impact of prior nicotine replacement therapy on smoking cessation efficacy

Michael J. Durcan, Jonathan White, Douglas E. Jorenby, Michael C. Fiore, Stephen I. Rennard, Scott J. Leischow, Mitchell A. Nides, John A. Ascher, J. Andrew Johnston

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objective: To examine previous use of nicotine replacement therapy (NRT) on the smoking-cessation efficacy of bupropion sustained release (SR). Methods: Secondary analysis of a parallel-group, randomized, double-blind, placebo-controlled study. Smokers who had, based on self-report, no previous history of NRT (N=453) or who had used NRT at least once (N=440) were randomized to receive placebo, bupropion SR, nicotine transdermal system (NTS), or a combination of bupropion SR and NTS. Results: Bupropion SR showed similar efficacy in participants with or without previous use of NRT. Conclusion: Bupropion SR is effective in promoting smoking abstinence regardless of prior NRT use.

Original languageEnglish (US)
Pages (from-to)213-220
Number of pages8
JournalAmerican Journal of Health Behavior
Volume26
Issue number3
DOIs
StatePublished - Jan 1 2002

Fingerprint

Smoking Cessation
Nicotine
Bupropion
nicotine
smoking
Therapeutics
Placebos
secondary analysis
Self Report
Smoking
Group

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health

Cite this

Durcan, M. J., White, J., Jorenby, D. E., Fiore, M. C., Rennard, S. I., Leischow, S. J., ... Johnston, J. A. (2002). Impact of prior nicotine replacement therapy on smoking cessation efficacy. American Journal of Health Behavior, 26(3), 213-220. https://doi.org/10.5993/AJHB.26.3.6

Impact of prior nicotine replacement therapy on smoking cessation efficacy. / Durcan, Michael J.; White, Jonathan; Jorenby, Douglas E.; Fiore, Michael C.; Rennard, Stephen I.; Leischow, Scott J.; Nides, Mitchell A.; Ascher, John A.; Johnston, J. Andrew.

In: American Journal of Health Behavior, Vol. 26, No. 3, 01.01.2002, p. 213-220.

Research output: Contribution to journalArticle

Durcan, MJ, White, J, Jorenby, DE, Fiore, MC, Rennard, SI, Leischow, SJ, Nides, MA, Ascher, JA & Johnston, JA 2002, 'Impact of prior nicotine replacement therapy on smoking cessation efficacy', American Journal of Health Behavior, vol. 26, no. 3, pp. 213-220. https://doi.org/10.5993/AJHB.26.3.6
Durcan MJ, White J, Jorenby DE, Fiore MC, Rennard SI, Leischow SJ et al. Impact of prior nicotine replacement therapy on smoking cessation efficacy. American Journal of Health Behavior. 2002 Jan 1;26(3):213-220. https://doi.org/10.5993/AJHB.26.3.6
Durcan, Michael J. ; White, Jonathan ; Jorenby, Douglas E. ; Fiore, Michael C. ; Rennard, Stephen I. ; Leischow, Scott J. ; Nides, Mitchell A. ; Ascher, John A. ; Johnston, J. Andrew. / Impact of prior nicotine replacement therapy on smoking cessation efficacy. In: American Journal of Health Behavior. 2002 ; Vol. 26, No. 3. pp. 213-220.
@article{4055cede99214bc6bf16f73d36945db9,
title = "Impact of prior nicotine replacement therapy on smoking cessation efficacy",
abstract = "Objective: To examine previous use of nicotine replacement therapy (NRT) on the smoking-cessation efficacy of bupropion sustained release (SR). Methods: Secondary analysis of a parallel-group, randomized, double-blind, placebo-controlled study. Smokers who had, based on self-report, no previous history of NRT (N=453) or who had used NRT at least once (N=440) were randomized to receive placebo, bupropion SR, nicotine transdermal system (NTS), or a combination of bupropion SR and NTS. Results: Bupropion SR showed similar efficacy in participants with or without previous use of NRT. Conclusion: Bupropion SR is effective in promoting smoking abstinence regardless of prior NRT use.",
author = "Durcan, {Michael J.} and Jonathan White and Jorenby, {Douglas E.} and Fiore, {Michael C.} and Rennard, {Stephen I.} and Leischow, {Scott J.} and Nides, {Mitchell A.} and Ascher, {John A.} and Johnston, {J. Andrew}",
year = "2002",
month = "1",
day = "1",
doi = "10.5993/AJHB.26.3.6",
language = "English (US)",
volume = "26",
pages = "213--220",
journal = "American Journal of Health Behavior",
issn = "1087-3244",
publisher = "PNG Publications",
number = "3",

}

TY - JOUR

T1 - Impact of prior nicotine replacement therapy on smoking cessation efficacy

AU - Durcan, Michael J.

AU - White, Jonathan

AU - Jorenby, Douglas E.

AU - Fiore, Michael C.

AU - Rennard, Stephen I.

AU - Leischow, Scott J.

AU - Nides, Mitchell A.

AU - Ascher, John A.

AU - Johnston, J. Andrew

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Objective: To examine previous use of nicotine replacement therapy (NRT) on the smoking-cessation efficacy of bupropion sustained release (SR). Methods: Secondary analysis of a parallel-group, randomized, double-blind, placebo-controlled study. Smokers who had, based on self-report, no previous history of NRT (N=453) or who had used NRT at least once (N=440) were randomized to receive placebo, bupropion SR, nicotine transdermal system (NTS), or a combination of bupropion SR and NTS. Results: Bupropion SR showed similar efficacy in participants with or without previous use of NRT. Conclusion: Bupropion SR is effective in promoting smoking abstinence regardless of prior NRT use.

AB - Objective: To examine previous use of nicotine replacement therapy (NRT) on the smoking-cessation efficacy of bupropion sustained release (SR). Methods: Secondary analysis of a parallel-group, randomized, double-blind, placebo-controlled study. Smokers who had, based on self-report, no previous history of NRT (N=453) or who had used NRT at least once (N=440) were randomized to receive placebo, bupropion SR, nicotine transdermal system (NTS), or a combination of bupropion SR and NTS. Results: Bupropion SR showed similar efficacy in participants with or without previous use of NRT. Conclusion: Bupropion SR is effective in promoting smoking abstinence regardless of prior NRT use.

UR - http://www.scopus.com/inward/record.url?scp=0036584107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036584107&partnerID=8YFLogxK

U2 - 10.5993/AJHB.26.3.6

DO - 10.5993/AJHB.26.3.6

M3 - Article

C2 - 12018757

AN - SCOPUS:0036584107

VL - 26

SP - 213

EP - 220

JO - American Journal of Health Behavior

JF - American Journal of Health Behavior

SN - 1087-3244

IS - 3

ER -